Quinoline and quinoxaline compounds as PDGF-R and/or LCK tyrosine kinase inhibitors
A Standard patent application filed on 23 November 1999 credited to Spada, Alfred P.
;
Myers, Michael R
;
He, Wei
Details
Application number :
20284
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Quinoline and quinoxaline compounds as PDGF-R and/or LCK tyrosine kinase inhibitors
Inventor :
Spada, Alfred P.
;
Myers, Michael R
;
He, Wei
Agent name :
WATERMARK PATENT AND TRADE MARKS ATTORNEYS
Address for service :
Level 2 302 Burwood Road HAWTHORN VIC 3122
Filing date :
23 November 1999
Associated companies :
Applicant name :
Aventis Pharmaceuticals Inc.
Applicant address :
55 Corporate Drive, Bridgewater, New Jersey, 08807 United States Of America